Corporate Culture
- Vision
- A trailblazer in nutritional health innovation
The trusted partner for our clients
- Mission
- Advance nutrition science and technology to deliver value to health
- Values
- Service, Innovative, Responsible, Initiative, Open
仙乐健康以技术立本，2023年研发投入达1.1亿元。经过30多年积累，现已拥有一支领先的复合型研发团队、形成全球5大研发中心布局、80+海内外发明专利、6000+成熟营养健康食品配方。我们将以领先的科研实力，助您打造更有竞争力的产品
1993
SIRIO was founded
Began pharmaceutical manufacturing
1999
Began manufacturing nutritional health foods
2002
Launched export operations
2003
Achieved GMP certification for pharmaceuticals
Expanded to North American and European markets
2007
Opened a second facility at the Shantou production site, expanding to multi-dosage manufacturing
2010
Opened US Branch
2013
Launched the plant-based softgel production line
2015
Established Ma'anshan Health Industrial Park
2016
Acquired Ayanda GmbH (Germany), now is Sirio Pharma Germany
Obtained UL certification (USA)
2019
Listed on the A-share market (300791.SZ)
2021
Launched the digital transformation initiative for the health and wellness industry
2022
Established the Shanghai R&D Center
Launched the Ma’anshan smart warehouse
2023
Acquired Best Formulations LLC (USA)
Started operations at Zhuhai Bonded Factory
2024
Launched a new automated packaging line in Sirio Pharma Germany
NF-Ubidecarenone Chewable Gels included in the United States Pharmacopeia
Launched the E-Cube Bioinspired Efficacy Technology Platform
仙乐健康业务覆盖50多个国家与地区，累计服务全球70亿人次